TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04810624

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy
Study: NCT05392738

Intervention type: DEVICE
Intervention: I-Stent implantation
Description: I-Stent implantation
Study: NCT05753852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic Acid
Description: Tauroursodeoxycholic acid (TUDCA) 250 mg capsules Doses: 4 capsules (1 g) twice daily 10-15 minutes after a meal Mode of administration: orally Duration: 18 months
Study: NCT06502769

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Therapeutic Exercise
Description: A therapeutic exercise program will be carried out

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Exercise
Description: A therapeutic exercise program will be carried out

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pain Neurophysiology Education
Description: A PNE program will be carried out
Study: NCT04712578

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Caffeinated pre-workout supplement
Description: The intervention will consist of consuming a standardized meal followed by one serving of the commercially available Pulse caffeinated pre-workout supplement (Legion Athletics, Inc.).

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-caffeinated pre-workout supplement
Description: The intervention will consist of consuming a standardized meal followed by one serving of the commercially available Pulse non-caffeinated pre-workout supplement (Legion Athletics, Inc.).

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The intervention will consist of consuming a standardized meal followed by a placebo beverage.
Study: NCT05429723

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10383
Description: HS-10383 administered as one 50 mg, 150 mg, 450 mg and 900 mg tablet once daily, depending upon randomization.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HS-10383 Placebo
Description: Placebo for HS-10383
Study: NCT05794516

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZB004
Description: ZB004 single doses administered subcutaneously as solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo single doses administered subcutaneously as solution
Study: NCT05218135

Intervention type: OTHER
Intervention: Intervention
Description: Learning session 1: explain key interventions, explain BIC methodology, retrospective patient record analysis Learning session 2: feedback report, share best practices, discussion, set priorities, teaching and improvement, retrospective patient record analysis Learning session 3: feedback report, share best practices, discussion, set priorities, teaching and improvement, retrospective patient record analysis Learning session 4: feedback report
Study: NCT04810624

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention and Changing Habits (REACH+)
Description: Psychotherapy
Study: NCT06553339

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral HS-10516
Description: Oral HIF-2α inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral HS-10516
Description: Oral HIF-2α inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral HS-10516
Description: Oral HIF-2α inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral HS-10516
Description: Oral HIF-2α inhibitor
Study: NCT05679687

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment
Description: In this study, allogeneic anti-CD19 CAR T cells (ThisCART19A) infusion is used as a bridge therapy to hematopoietic stem cell transplantation to treat patients with refractory or relapsed CD19 positive B cell acute lymphoblastic leukemia. Lymphodepletion conditioning before CAR T cell infusion consists of fludarabine, CTX and VP-16.
Study: NCT05160077

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Multispectral optoacoustic tomography (MSOT)
Description: MSOT Acuity Echo, iThera medical, Munich
Study: NCT06389500

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab, IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib, PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hepatic Arterial Infusion Chemotherapy
Description: GC regimen±5-FU
Study: NCT05543967

Intervention type: BEHAVIORAL
Intervention: Cognitive assessments
Description: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Rey Auditory Verbal Learning Test (RAVLT), Boston Naming Test (BNT), Digit Span Test (DST), Trail Making Test (TMT).

Intervention type: BEHAVIORAL
Intervention: Cognitive assessments
Description: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Rey Auditory Verbal Learning Test (RAVLT), Boston Naming Test (BNT), Digit Span Test (DST), Trail Making Test (TMT).

Intervention type: OTHER
Intervention: Olfactory function measurements
Description: Olfactory Threshold, Odor Identification Score, Odor Memory Score.

Intervention type: OTHER
Intervention: Olfactory function measurements
Description: Olfactory Threshold, Odor Identification Score, Odor Memory Score.

Intervention type: OTHER
Intervention: Functional magnetic resonance imaging
Description: resting-state fMRI, odor-induced fMRI.

Intervention type: OTHER
Intervention: Functional magnetic resonance imaging
Description: resting-state fMRI, odor-induced fMRI.
Study: NCT05160077

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Multispectral optoacoustic tomography (MSOT)
Description: MSOT Acuity Echo, iThera medical, Munich

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Multispectral optoacoustic tomography (MSOT)
Description: MSOT Acuity Echo, iThera medical, Munich
Study: NCT05883592

Intervention type: DEVICE
Intervention: Fabulous Thoracic Aortic Stent System
Description: Endovascular treament in patients with aortic dissection with Fabulous Thoracic Aortic Stent System
Study: NCT06361173

Intervention type: OTHER
Intervention: BMT4me
Description: Caregivers will pilot test a Spanish version of the BMT4me app at a single time point.
Study: NCT05602116

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Description: The Investigational Product is a C2C_ASC cell product (Cell2Cure®, Cell2Cure Aps, Denmark).~C2C_ASC is an advanced therapy investigational medicinal product (ATIMP) manufactured from abdominal adipose tissue derived mesenchymal stromal cells (ASC) from healthy donors. C2C_ASC is aseptically procured and manufactured according to tissue law and GMP by Cell2Cure ApS or Cardiology Stem Cell Center, Rigshospitalet, Copenhagen, Denmark, using manual isolation of cells from abdominal fat tissue, xeno-free cell expansion in automated closed bioreactor systems and cryopreservation of the final product.~The active substance is the in vitro expanded ASCs. The final product, C2C_ASC, is provided as a cryopreserved suspension of 50 million ASCs per ml with a total volume of 1,3 ml per vial. The excipient is CryoStor10 (Biolife Solutions), holding 10% DMSO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Description: The Investigational Product is a C2C_ASC cell product (Cell2Cure®, Cell2Cure Aps, Denmark).~C2C_ASC is an advanced therapy investigational medicinal product (ATIMP) manufactured from abdominal adipose tissue derived mesenchymal stromal cells (ASC) from healthy donors. C2C_ASC is aseptically procured and manufactured according to tissue law and GMP by Cell2Cure ApS or Cardiology Stem Cell Center, Rigshospitalet, Copenhagen, Denmark, using manual isolation of cells from abdominal fat tissue, xeno-free cell expansion in automated closed bioreactor systems and cryopreservation of the final product.~The active substance is the in vitro expanded ASCs. The final product, C2C_ASC, is provided as a cryopreserved suspension of 50 million ASCs per ml with a total volume of 1,3 ml per vial. The excipient is CryoStor10 (Biolife Solutions), holding 10% DMSO.
Study: NCT05126719

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRG003
Description: Administered intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine tablets
Description: Administered peros

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel injection
Description: Administered intravenously
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.
Study: NCT05799196

Intervention type: PROCEDURE
Intervention: Microfracture
Description: Microfracture was made in the non-weight bearing chondral to provide the release of MSC and growth factor.

Intervention type: PROCEDURE
Intervention: Microfracture
Description: Microfracture was made in the non-weight bearing chondral to provide the release of MSC and growth factor.
Study: NCT05302219

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory rate
Description: The participant alternates respiratory rates of 30, 15 and 7.5 breaths/min. Breathe each frequency for 2 minutes with a one-minute break.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tidal volume
Description: The participant alternates tidal volumes of approx. 2, 1 and 0.5 litres. Breathe each tidal volume for 2 minutes with a one-minute break.
Study: NCT06553833

Intervention type: BIOLOGICAL
Intervention: Allogeneic transfusion
Description: Anemia is treated by administering donor red cells, and bleeding or coagulopathy by plasma, platelets or other donor blood products.

Intervention type: BIOLOGICAL
Intervention: Allogeneic transfusion
Description: Anemia is treated by administering donor red cells, and bleeding or coagulopathy by plasma, platelets or other donor blood products.

Intervention type: OTHER
Intervention: Patient Blood Management
Description: PBM is a strategy to manage the participants own blood. Its focus is on anemia, bleeding and coagulation management (using predominantly pharmaceutical and technological means).

Intervention type: OTHER
Intervention: Patient Blood Management
Description: PBM is a strategy to manage the participants own blood. Its focus is on anemia, bleeding and coagulation management (using predominantly pharmaceutical and technological means).
Study: NCT05634317

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smartphone delivered Behavioral activation
Description: Outline:~Session 0 45-minute psychoeducation on caregiving and depression~Session 1 Review the present use of time and use the monitoring form~Session 2 Brain-storm pleasant events and schedule pleasant activities~Session 3 Review scheduling of events and discuss how to improve~Session 4 Review modifications and consolidate gains on scheduling~Session 5 Review present social support and explore new sources of support~Session 6 Examine communication skills and explore new options~Session 7 Review new communications and discuss how to improve~Session 8 Review modification and consolidate gains on support

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smartphone delivered Mindfulness
Description: Outline:~Session 0 45-minute psychoeducation on caregiving and depression~Session 1 The Raisin exercise (eating meditation) and12-min body scan~Session 2 Exercises on thoughts and feelings 12-min body scan~Session 3 Exercises focusing on unpleasant experiences, practicing seeing and hearing , sitting meditation, 3-min breathing space, and mindful stretching and breath meditation~Session 4 Practicing seeing and hearing, mindful communication, 3-min breathing space, and sitting meditation~Session 5 Mindful walking, 3-min breathing space, and sitting meditation~Session 6 Sitting meditation, exercises on thoughts and alternative viewpoints, and 3-min breathing space (responsive)~Session 7 Sitting meditation, activity and mood exercise, identifying habitual emotional reactions to difficulties, and 3-min breathing space (responsive)~Session 8 12-min body scan, exercise on looking forward, and exercise on preparing for the future
Study: NCT04691778

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CTO PCI with the first-choice Gladius guidewire
Description: CTO PCI using antegrade wiring strategy with the first-choice Gladius guidewire

Intervention type: PROCEDURE
Group type: OTHER
Intervention: CTO PCI without the first-choice Gladius guidewire
Description: CTO PCI using standard antegrade wire escalation strategy
Study: NCT03384537

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Listerine total care zero
Description: reducing intra-oral cariogenic microorganism.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine Mouthwash (0.2%).
Description: Chlorhexidine Mouthwash (0.2%).
Study: NCT05302219

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Apnea
Description: The participant simulates three apneic pauses lasting 1 minute with a two-minute break.
Study: NCT05930392

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Gingival depigmentation using microsurgery
Description: GINGIVAL DEPIGMENTATION USING MICROSURGICAL BLADE AND MAGNIFICATION LOUPES

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional surgical depigmentation
Description: GINGIVAL DEPIGMENTATION USING CONVENTIONAL SURGICAL TECHNIQUE
Study: NCT05095649

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Regulatory T-cell enriched infusion
Description: Enrichment of cluster of differentiation 25hi regulatory T cells from cluster of differentiation antigen 8 and/or cluster of differentiation antigen19 pre-depleted leukapheresis products.
Study: NCT05288166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: Administered orally.
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.
Study: NCT06424873

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET/CT with FDG or FES
Description: The study consists of an additional 50 minutes of imaging during the radiotracer's uptake phase prior to their clinical scan (standard of care).
Study: NCT03798145

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Retinotomy
Description: Surgical removal of small areas of retinal to increase outflow through the posterior drainage pathway.
Study: NCT05288166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone
Description: Administered orally.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abiraterone
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone or Prednisolone
Description: Administered orally.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone or Prednisolone
Description: Administered orally.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for Abemaciclib
Description: Administered orally.
Study: NCT05472896

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cTACE
Description: transcatheter arterial chemoembolization with
Study: NCT05968456

Intervention type: OTHER
Intervention: Data collection
Description: Observational study in patients undergoing thoracic, cardiac and vascular surgery.

Intervention type: OTHER
Intervention: Data collection
Description: Observational study in patients undergoing thoracic, cardiac and vascular surgery.
Study: NCT04417777

Intervention type: GENETIC
Intervention: Blood Test
Description: Blood analysis

Intervention type: GENETIC
Intervention: Blood Test
Description: Blood analysis
Study: NCT05472896

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cTACE
Description: transcatheter arterial chemoembolization with
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.
Study: NCT05472896

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dicycloplatin (TP21)
Description: the dosage of dicycloplatin was based on the body surface area (550 mg/m2) according to previous research. The volume ratio of lipiodol to dicycloplatin aqueous solution was 1:1. The volume of lipiodol used was calculated by the size and vascularity of the tumor, within 20 mL.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: the dosage of epirubicin was determined according to the tumor size, and the maximum dose was limited to 40 mg. The volume ratio of lipiodol to epirubicin aqueous solution was 2:1. The volume of lipiodol used was calculated by the size and vascularity of the tumor, within 20 mL.
Study: NCT05746130

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plastic-free diet program
Description: Applying the plastic-free diet as four meals (three main meals, one snack) in pension kitchen. Promoting of glass water bottle giving and daily use.~Interactive education program: Slogan competition, school board preparation, short film shooting, school canteen visits and plastic-free nutrition day event with the adolescents for four weeks by the researcher.~Peer education will doing by Adolescents with Packaged Product Low Usage Feedback about BPA levels in theirs urinary sample.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Plastic-free diet education program
Description: Interactive education program: Slogan competition, school board preparation, short film shooting, school canteen visits and plastic-free nutrition day event with the adolescents for four weeks by the researcher.~Peer education will doing by Adolescents with Packaged Product Low Usage Feedback about BPA levels in theirs urinary sample

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plastic-free diet education program
Description: Interactive education program: Slogan competition, school board preparation, short film shooting, school canteen visits and plastic-free nutrition day event with the adolescents for four weeks by the researcher.~Peer education will doing by Adolescents with Packaged Product Low Usage Feedback about BPA levels in theirs urinary sample

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BPA exposure feedback
Description: Feedback about BPA levels in theirs urinary sample

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BPA exposure feedback
Description: Feedback about BPA levels in theirs urinary sample

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BPA exposure feedback
Description: Feedback about BPA levels in theirs urinary sample
Study: NCT05595122

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EUS-CDS
Description: EUS-CDS with FCSEMS through LAMS
Study: NCT05331391

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief mobile SMART Exercise Support Program
Description: Patients will receive 1) a brief SMART Exercise individual face-to-face session; 2) a theory-based instant messaging (WhatsApp/WeChat) and telephone-delivered health coaching on a 2-stage tapering schedule. Stage 1 (week 1 to 6): daily messages and two biweekly phone calls for exercise habit formation. Stage 2 (week 7 to 12): messages twice a week and monthly phone calls for exercise habit maintenance.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Brief mobile SMART Exercise Support Program
Description: Patients will receive 1) a brief SMART Exercise individual face-to-face session; 2) a theory-based instant messaging (WhatsApp/WeChat) and telephone-delivered health coaching on a 2-stage tapering schedule. Stage 1 (week 1 to 6): daily messages and two biweekly phone calls for exercise habit formation. Stage 2 (week 7 to 12): messages twice a week and monthly phone calls for exercise habit maintenance.
Study: NCT06427187

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: an array of devices are used in thrombectomy. These include guide catheters, stent-retrievers, microcatheters, aspiration catheters, and aspiration pump systems
Description: each patient with distal vessel occlusion subjected to mechanical thrombectomy using aspiration technique or stent retriever
Study: NCT05829850

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SYNOLIS VA 40/80
Description: Three 2mL injections of SYNOLIS VA 40/80, one week apart
Study: NCT04922216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core
Description: Behavioral weight loss core includes behavioral lessons, activity tracker, daily self-weighing, weekly tailored feedback summary.